News from rigel pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 09, 2010, 07:30 ET

Rigel and AstraZeneca Awarded 'Licensing Deal of the Year' by Scrip for Fostamatinib Collaboration

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it received the Licensing Deal of the Year award from Scrip Intelligence at the...

Nov 23, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel to Present at Piper Jaffray Health Care Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...

Nov 02, 2010, 07:00 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel Announces Third Quarter 2010 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the third quarter and nine months ended September 30,...

Oct 28, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel Announces Presentations at Two Investor Conferences

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Raul R. Rodriguez,...

Sep 29, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel Earns Milestone Payments From AstraZeneca

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major...

Sep 09, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel to Present at Stifel Nicolaus Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...

Aug 03, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel Announces Second Quarter 2010 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the second quarter and six months ended June 30, 2010. For the...

Jul 28, 2010, 07:30 ET
Rigel Pharmaceuticals, Inc.  (PRNewsFoto/Rigel Pharmaceuticals, Inc.)

Rigel to Present at BMO Capital Markets Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...

Jun 03, 2010, 07:30 ET

Rigel Announces Presentation at Three Investor Conferences

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive...

Jun 01, 2010, 07:30 ET

Rigel Pharmaceuticals Names Raul Rodriguez President

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the promotion of three members of senior management, effective immediately.   Raul...

May 04, 2010, 07:30 ET

Rigel Announces First Quarter 2010 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2010. For the first quarter...

Apr 30, 2010, 07:30 ET

Rigel Receives Innovators Award of Excellence in Life Sciences

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County...

Mar 29, 2010, 07:30 ET

Rigel Announces Expiry of Waiting Period Under Hart-Scott-Rodino Act for Licensing Agreement With Astrazeneca

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements...

Mar 18, 2010, 07:30 ET

Rigel to Webcast Investor Day on March 25, 2010

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will provide a live webcast for its Investor Day on March 25, 2010 at 10:00am...

Mar 17, 2010, 07:30 ET

Rigel to Present at Barclays Capital Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...

Mar 05, 2010, 07:30 ET

Rigel to Present at Cowen and Company Health Care Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...

Mar 02, 2010, 07:00 ET

Rigel Announces Fourth Quarter and Year End 2009 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ended December 31, 2009. For the...

Feb 16, 2010, 02:01 ET

Rigel to Host Conference Call Today to Discuss Its Partnership With AstraZeneca on Fostamatinib Disodium (R788)

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its senior management team will host a conference call, and simultaneous audio webcast,...

Feb 16, 2010, 02:00 ET

AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)

AstraZeneca and Rigel Pharmaceuticals (Nasdaq: RIGL) today announced an exclusive worldwide license agreement for the global development and...

Feb 05, 2010, 07:30 ET

Rigel to Present at BIO CEO & Investor Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to...